<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mehta</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Kabrawala</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Nandwani</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Desai</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Bhayani</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Patel</surname>
   </name>
   <etal/>
  </person-group>. (
  <year>2018</year>). 
  <article-title>Safety and efficacy of sofosbuvir and daclatasvir for hepatitis C virus infection in patients with β-thalassemia major</article-title>. 
  <source>J. Clin. Exp. Hepatol</source>. 
  <volume>8</volume>, 
  <fpage>3</fpage>–
  <lpage>6</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.jceh.2017.06.002</pub-id>
  <?supplied-pmid 29743790?>
  <pub-id pub-id-type="pmid">29743790</pub-id>
 </mixed-citation>
</ref>
